About us

The Senior Management Team

Antisoma has a highly experienced Senior Management Team made up of individuals who have held senior positions in international pharmaceutical and biotechnology companies and financial institutions.

Chief Medical Officer

Gary Acton, MA, MBBS MRCP

View details

		Gary, 51, joined Antisoma as Chief Medical Officer in April 2006, with 19 years’ experience in the biotechnology and pharmaceutical sectors. He was Vice President of Clinical Development at Vernalis for five years and has also held the posts of European Managing Director of Cell Therapeutics, Inc. and UK Director of Clinical Research for Fujisawa.
	Close

VP Business Development

Nicholas Adams, BSc

View details

		Nick, 46, was appointed Director of Business Development in November 2003. Prior to this he was Business Development Manager for four years. Before joining Antisoma, Nick held R&D positions at Ciba-Geigy, Eisai Ltd and Cephalon Inc.
	Close

General Manager, Autoimmune

Michael Boss, PhD, MBA

View details

		Mike, 55, joined Antisoma in June 2008 as General Manager, Autoimmune through the acquisition of Xanthus Pharmaceuticals where he held positions as Chief Business Officer and Chief Operating Officer. Previously, he has held posts as Vice President at Elan, and Vice President of Operations at Athena Diagnostics.
	Close

VP Marketing & Communications

Daniel Elger, BA, PhD

View details

		Daniel, 40, was appointed Director of Communications in April 2005, having been Head of Corporate Communications at Antisoma since 2002. Before joining Antisoma he worked for medical publishing companies and two pharmaceutical communications consultancies, Blackwell Healthcare and Avenue HKM.
	Close

VP Regulatory, Pharmaceutical and Business Ops

Sharon Grimster, BSc

View details

		Sharon, 51, was appointed Director of Project Management and Manufacturing in April 2004. Previously she held a variety of senior research, manufacturing and project management roles at Celltech. From 2002 to 2004, Sharon was Director of Westerly Projects Ltd. Sharon has chaired the Manufacturing Advisory Committee for the BIA since 2003.
	Close

VP Clinical Operations

Chris Smyth, BSc, PhD, MBA

View details

		Chris, 42, was appointed VP, US Operations in 2007, having been Head of Clinical Operations at Antisoma since July 2003. Before joining Antisoma he was General Manager of the CRO, CPR Europe. Prior to that he held the positions of Director, Clinical Operations and Director, Clinical Monitoring, Northern Europe for MDS Pharma Services.
	Close